iA Global Asset Management »

Zenas Biopharma shares owned by iA Global Asset Management

Quarter-by-quarter ownership of Zenas Biopharma (ZBIO) shares owned by iA Global Asset Management from 13F filings

Historical chart of iA Global Asset Management investment in Zenas Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Zenas Biopharma held by iA Global Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zenas Biopharma by iA Global Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $4.2M 216k 19.55

More positions owned by iA Global Asset Management

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Mastercard Cl A (MA)
Thermo Fisher Scientific (TMO)
iShares iBoxx USD High Yield Corporate Bond ETF Iboxx Hi Yd Etf (HYG)
State Street SPDR Bloomberg Short Term High Yield Bond ETF State Street Spd (SJNK)
CMS Energy Corporation (CMS)
Wal-Mart Stores (WMT)
Visa Com Cl A (V)

View all positions for iA Global Asset Management

Top funds holding Zenas Biopharma

FMR
Sr One Capital Management
NEA Management Company
Enavate Sciences GP
Federated Investors
Capital Research and Management Company - Division 3
Fairmount Funds Management
BlackRock
NVP Associates
Vanguard Group
Vanguard Capital Management
Polar Capital Holdings
Alliancebernstein
Wellington Management Company
EcoR1 Capital

View all funds holding Zenas Biopharma